Grail is a healthcare company that develops and commercializes blood tests for early cancer detection. The company's tests use a combination of machine learning, genomics, and clinical data to detect cancer at an early stage, when it is most treatable. Grail was founded in 2016 and is headquartered in Redwood City, California.